Immunogenicity and Safety of a Booster Dose of a Quadrivalent Meningococcal Conjugate Vaccine in Children
Clinical trial NCT03476135 · COMPLETED
Trial details
- NCT number
- NCT03476135
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-27
- Primary completion
- 2018-09-10
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.